Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
3.800
+0.120 (3.26%)
At close: Jul 3, 2025, 1:00 PM
3.850
+0.050 (1.32%)
After-hours: Jul 3, 2025, 3:56 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Artificial Intelligence-driven DNA Biomarker Testing Technology
17.07K
Log In
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth
1696.32%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
17.07K
Log In
United States Growth
1696.32%
Log In